Shanghai MicuRx Pharmaceutical Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Yuan Zhengyu
Chief executive officer
CN¥3.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.05% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
Shanghai MicuRx Pharmaceutical Co., Ltd.'s (SHSE:688373) Shares Climb 30% But Its Business Is Yet to Catch Up
Dec 02
There's Reason For Concern Over Shanghai MicuRx Pharmaceutical Co., Ltd.'s (SHSE:688373) Massive 30% Price Jump
Dec 02Shanghai MicuRx Pharmaceutical Co., Ltd.'s (SHSE:688373) 26% Share Price Surge Not Quite Adding Up
Apr 07CEO
Yuan Zhengyu (69 yo)
no data
Tenure
CN¥3,843,100
Compensation
Dr. Zhengyu Yuan serves as CEO at Shanghai MicuRx Pharmaceutical Co., Ltd. since March 2023 and served as its General Manager until March 2023. He serves as Chairman at Shanghai MicuRx Pharmaceutical Co.,...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 15:57 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai MicuRx Pharmaceutical Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mingrui Wang | Everbright Securities Co. Ltd. |